BK Polyomavirus in Renal Transplantation: Virological Notes for Monitoring and Diagnosis.

Polyomavirus-associated nephropathy was first reported over 50 years ago. However, it still represents a cause of renal injury in kidney transplant recipients, particularly in the first two years post-transplantation, with occurrence rates of 1-10%. The role played by immunosuppression in viral reactivation is well acknowledged, and the modulation of its level is the main strategy for clinical management. Viral and immunological evaluation are fundamental for optimizing its diagnostic and therapeutic pathway. In this review, the main features of BK polyomavirus and associated nephropathy in renal transplant patients are addressed and discussed from a virological point of view; the role of BK polyomavirus in hematopoietic stem cell transplantation and other solid-organ transplant patients is also briefly reported.